EVH — Evolent Health, Inc.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1628908 ·
Last close
$3.65
Market Cap
$412.67M
52W High
$8.98
52W Low
$2.10
ADV30
2,398,221
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 652,520,000 | 80,836,000 | -9,561,000 | -28,364,000 | 1,971,894,000 | 115,703,000 | 1,588,671,000 |
| Mar 2026 | 496,246,000 | 83,774,000 | -10,599,000 | -26,632,000 | 1,878,847,000 | 142,028,000 | 1,482,454,000 |
| Dec 2025 | 468,719,000 | 97,253,000 | -20,440,000 | -429,131,000 | 1,899,236,000 | 151,856,000 | 1,484,042,000 |
| Sep 2025 | 479,533,000 | 99,774,000 | -1,433,000 | -20,864,000 | 2,453,459,000 | 116,650,000 | 1,611,226,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$54,316,000
Investing CF
$-31,026,000
Financing CF
$-149,817,000
CapEx
$-29,978,000
Dividends Paid
$-1,929,000
Buybacks
$0
EPS Diluted TTM
$-4.57
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,370,323,000
Inventory
—
Receivables
$449,118,000
ST Investments
—
EBIT TTM
$-433,503,000
Pretax Income TTM
$-502,137,000
Interest Exp TTM
$68,634,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,097,017,984
EBITDA
$61,037,000
Free Cash Flow
$184,295,008
Enterprise Value
$1,328,449,664
Total Cash
$115,703,000
Total Debt
$970,433,984
Shares Out
113,059,335
Trailing EPS
$-4.49
Book Value
$3.40
ROE
-67.0%
ROA
-0.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,876,229,000 | -19,834,000 | -534,510,000 | 1,899,236,000 | 1,484,042,000 | 415,194,000 | 38,843,000 |
| Dec 2024 | 2,554,741,000 | -14,067,000 | -61,623,000 | 2,544,411,000 | 1,543,152,000 | 1,001,259,000 | 18,765,000 |
| Dec 2023 | 1,963,896,000 | -21,055,000 | -113,040,000 | 2,680,308,000 | 1,612,607,000 | 1,067,701,000 | 142,582,000 |
| Dec 2022 | 1,352,013,000 | -19,880,000 | -19,164,000 | 1,817,293,000 | 957,876,000 | 859,417,000 | -11,553,000 |
TTM Snapshot
Revenues TTM
$1,968,650,000
NetIncome TTM
$-110,956,000
OpCashFlow TTM
$0
Assets (Latest)
$1,899,236,000
Forward EPS
$0.39
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NBB | Nuveen Taxable Municipal Income Fund | $413.00M | $14.05 | — |
| JOUT | JOHNSON OUTDOORS INC | $410.26M | $44.24 | — |
| NPFD | Nuveen Variable Rate Preferred & Income Fund | $415.86M | $17.21 | — |
| WLYB | JOHN WILEY & SONS, INC. | $418.39M | $47.77 | — |
| KIO | KKR Income Opportunities Fund | $418.87M | $10.22 | — |
News headlines (Yahoo Finance, 1h cache)
3 Reasons to Avoid EVH and 1 Stock to Buy Instead
2026-09-21 19:26 · Yahoo
TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
2026-09-21 14:00 · Yahoo
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses
2026-09-16 17:08 · Yahoo
1 Value Stock with Promising Prospects and 2 That Underwhelm
2026-09-01 10:42 · Yahoo
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call
2026-08-15 03:09 · Yahoo
Evolent Health (EVH) Q2 2026 Earnings Call Transcript
2026-08-13 17:45 · Yahoo
Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Revenue Surges 31% and Guidance ...
2026-08-06 19:03 · Yahoo
Compared to Estimates, Evolent Health (EVH) Q2 Earnings: A Look at Key Metrics
2026-08-06 13:30 · Yahoo
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Find Risky
2026-09-12 00:43 · Yahoo
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
2026-08-16 04:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.